- Tips for Spending Holiday Time With Family Members Who Live with Dementia
- Tainted Cucumbers Now Linked to 100 Salmonella Cases in 23 States
- Check Your Pantry, Lay’s Classic Potato Chips Recalled Due to Milk Allergy Risk
- Norovirus Sickens Hundreds on Three Cruise Ships: CDC
- Not Just Blabber: What Baby’s First Vocalizations and Coos Can Tell Us
- What’s the Link Between Memory Problems and Sexism?
- Supreme Court to Decide on South Carolina’s Bid to Cut Funding for Planned Parenthood
- Antibiotics Do Not Increase Risks for Cognitive Decline, Dementia in Older Adults, New Data Says
- A New Way to Treat Sjögren’s Disease? Researchers Are Hopeful
- Some Abortion Pill Users Surprised By Pain, Study Says
Laser Device Approved for Nearsightedness
The VisuMax Femtosecond Laser has been approved by the U.S. Food and Drug Administration to treat nearsightedness in candidates 22 and older.
Nearsightedness, medically called myopia, is present when a person can see close objects clearly, but not objects farther away. Common causes include a misshapen cornea or excess length of the eyeball, the FDA said in a news release.
The procedure to permanently reshape the cornea is not appropriate for everyone, the agency said. Of 328 people clinically evaluated six months after having the surgery, 88 percent had 20/20 vision, the FDA said.
The most common complications from the procedure included surgical debris, dry eye, glare and the appearance of a halo.
The device is produced by Carl Zeiss Meditec Inc., based in Dublin, Calif.
More information
Learn more about this approval from the FDA.
Source: HealthDay
Copyright © 2024 HealthDay. All rights reserved.